These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 22131351)

  • 1. Mutations of ventricular essential myosin light chain disturb myosin binding and sarcomeric sorting.
    Lossie J; Ushakov DS; Ferenczi MA; Werner S; Keller S; Haase H; Morano I
    Cardiovasc Res; 2012 Mar; 93(3):390-6. PubMed ID: 22131351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human essential myosin light chain isoforms revealed distinct myosin binding, sarcomeric sorting, and inotropic activity.
    Petzhold D; Lossie J; Keller S; Werner S; Haase H; Morano I
    Cardiovasc Res; 2011 Jun; 90(3):513-20. PubMed ID: 21262909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Auto-inhibitory effects of an IQ motif on protein structure and function.
    Petzhold D; Lossie J; Behlke J; Keller S; Haase H; Morano I
    Biochem Biophys Res Commun; 2010 Jun; 396(4):939-43. PubMed ID: 20460111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanism regulating myosin and cardiac functions by ELC.
    Lossie J; Köhncke C; Mahmoodzadeh S; Steffen W; Canepari M; Maffei M; Taube M; Larchevêque O; Baumert P; Haase H; Bottinelli R; Regitz-Zagrosek V; Morano I
    Biochem Biophys Res Commun; 2014 Jul; 450(1):464-9. PubMed ID: 24911555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct interactions between actin and essential myosin light chain isoforms.
    Petzhold D; Simsek B; Meißner R; Mahmoodzadeh S; Morano I
    Biochem Biophys Res Commun; 2014 Jul; 449(3):284-8. PubMed ID: 24857983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes.
    Flavigny J; Souchet M; Sébillon P; Berrebi-Bertrand I; Hainque B; Mallet A; Bril A; Schwartz K; Carrier L
    J Mol Biol; 1999 Nov; 294(2):443-56. PubMed ID: 10610770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiomyopathic mutations in essential light chain reveal mechanisms regulating the super relaxed state of myosin.
    Sitbon YH; Diaz F; Kazmierczak K; Liang J; Wangpaichitr M; Szczesna-Cordary D
    J Gen Physiol; 2021 Jul; 153(7):. PubMed ID: 34014247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and spectroscopic studies of a familial hypertrophic cardiomyopathy mutation in Motif X of cardiac myosin binding protein-C.
    Brown LJ; Singh L; Sale KL; Yu B; Trent R; Fajer PG; Hambly BD
    Eur Biophys J; 2002 Sep; 31(5):400-8. PubMed ID: 12202917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Too light to be essential? Insights from FHC-related mutations in essential myosin light chains.
    Krüger M
    Cardiovasc Res; 2012 Mar; 93(3):381-2. PubMed ID: 22266750
    [No Abstract]   [Full Text] [Related]  

  • 10. Minigenes encoding N-terminal domains of human cardiac myosin light chain-1 improve heart function of transgenic rats.
    Haase H; Dobbernack G; Tünnemann G; Karczewski P; Cardoso C; Petzhold D; Schlegel WP; Lutter S; Pierschalek P; Behlke J; Morano I
    FASEB J; 2006 May; 20(7):865-73. PubMed ID: 16675844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypercontractile mutant of ventricular myosin essential light chain leads to disruption of sarcomeric structure and function and results in restrictive cardiomyopathy in mice.
    Yuan CC; Kazmierczak K; Liang J; Kanashiro-Takeuchi R; Irving TC; Gomes AV; Wang Y; Burghardt TP; Szczesna-Cordary D
    Cardiovasc Res; 2017 Aug; 113(10):1124-1136. PubMed ID: 28371863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in beta-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin-binding protein-C.
    Gruen M; Gautel M
    J Mol Biol; 1999 Feb; 286(3):933-49. PubMed ID: 10024460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point mutations in human beta cardiac myosin heavy chain have differential effects on sarcomeric structure and assembly: an ATP binding site change disrupts both thick and thin filaments, whereas hypertrophic cardiomyopathy mutations display normal assembly.
    Becker KD; Gottshall KR; Hickey R; Perriard JC; Chien KR
    J Cell Biol; 1997 Apr; 137(1):131-40. PubMed ID: 9105042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Cardiomyopathy Mutation in the Myosin Essential Light Chain Alters Actomyosin Structure.
    Guhathakurta P; Prochniewicz E; Roopnarine O; Rohde JA; Thomas DD
    Biophys J; 2017 Jul; 113(1):91-100. PubMed ID: 28700929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of the binding site of the C-terminal domain of cardiac myosin-binding protein-C on the myosin rod.
    Flashman E; Watkins H; Redwood C
    Biochem J; 2007 Jan; 401(1):97-102. PubMed ID: 16918501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial hypertrophic cardiomyopathy: a paradigm of the cardiac hypertrophic response to injury.
    Marian AJ; Roberts R
    Ann Med; 1998 Aug; 30 Suppl 1():24-32. PubMed ID: 9800880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 29 residue region of the sarcomeric myosin rod is necessary for filament formation.
    Sohn RL; Vikstrom KL; Strauss M; Cohen C; Szent-Gyorgyi AG; Leinwand LA
    J Mol Biol; 1997 Feb; 266(2):317-30. PubMed ID: 9047366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single serine in the carboxyl terminus of cardiac essential myosin light chain-1 controls cardiomyocyte contractility in vivo.
    Meder B; Laufer C; Hassel D; Just S; Marquart S; Vogel B; Hess A; Fishman MC; Katus HA; Rottbauer W
    Circ Res; 2009 Mar; 104(5):650-9. PubMed ID: 19168438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic analysis of the regulatory and essential myosin light chain genes: genetic variants and mutations in hypertrophic cardiomyopathy.
    Kabaeva ZT; Perrot A; Wolter B; Dietz R; Cardim N; Correia JM; Schulte HD; Aldashev AA; Mirrakhimov MM; Osterziel KJ
    Eur J Hum Genet; 2002 Nov; 10(11):741-8. PubMed ID: 12404107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of Cardiac Myosin with Cardiomyopathic Mutations in Essential Light Chains.
    Yampolskaya DS; Kopylova GV; Shchepkin DV; Bershitsky SY; Matyushenko AM; Levitsky DI
    Biochemistry (Mosc); 2022 Nov; 87(11):1260-1267. PubMed ID: 36509720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.